HK1013997A1 - Pyridazino quinoline compounds - Google Patents
Pyridazino quinoline compoundsInfo
- Publication number
- HK1013997A1 HK1013997A1 HK98115415A HK98115415A HK1013997A1 HK 1013997 A1 HK1013997 A1 HK 1013997A1 HK 98115415 A HK98115415 A HK 98115415A HK 98115415 A HK98115415 A HK 98115415A HK 1013997 A1 HK1013997 A1 HK 1013997A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- phenyl
- deriv
- substd
- opt
- furyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939321854A GB9321854D0 (en) | 1993-10-22 | 1993-10-22 | Pyridazino quinoline compounds |
| GB9417171A GB9417171D0 (en) | 1994-08-25 | 1994-08-25 | Pyridazino quinoline compounds |
| PCT/GB1994/002295 WO1995011244A1 (fr) | 1993-10-22 | 1994-10-20 | Composes de pyridazino quinoleine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1013997A1 true HK1013997A1 (en) | 1999-09-17 |
Family
ID=26303731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98115415A HK1013997A1 (en) | 1993-10-22 | 1998-12-24 | Pyridazino quinoline compounds |
Country Status (30)
| Country | Link |
|---|---|
| US (3) | US5744471A (fr) |
| EP (2) | EP1004582B1 (fr) |
| JP (1) | JP3583132B2 (fr) |
| KR (1) | KR100261209B1 (fr) |
| CN (1) | CN1053189C (fr) |
| AT (2) | ATE198072T1 (fr) |
| AU (2) | AU688393B2 (fr) |
| CA (1) | CA2171332A1 (fr) |
| CZ (1) | CZ292311B6 (fr) |
| DE (2) | DE69434380T2 (fr) |
| DK (2) | DK1004582T3 (fr) |
| ES (2) | ES2154686T3 (fr) |
| FI (2) | FI113865B (fr) |
| GB (1) | GB9420590D0 (fr) |
| GR (1) | GR3035080T3 (fr) |
| HK (1) | HK1013997A1 (fr) |
| HU (1) | HUT74161A (fr) |
| IL (1) | IL111266A (fr) |
| MY (2) | MY124316A (fr) |
| NO (1) | NO306995B1 (fr) |
| NZ (2) | NZ275472A (fr) |
| PL (1) | PL180679B1 (fr) |
| PT (2) | PT724583E (fr) |
| RU (1) | RU2168511C2 (fr) |
| SG (2) | SG59971A1 (fr) |
| SI (2) | SI0724583T1 (fr) |
| SK (1) | SK282491B6 (fr) |
| TW (1) | TW406082B (fr) |
| UA (1) | UA60291C2 (fr) |
| WO (1) | WO1995011244A1 (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9420590D0 (en) * | 1993-10-22 | 1994-11-30 | Zeneca Ltd | Pyridazino quinoline compounds |
| US6214826B1 (en) | 1994-11-12 | 2001-04-10 | Zeneca Limited | Pyridazino quinoline compounds |
| GB9422894D0 (en) * | 1994-11-12 | 1995-01-04 | Zeneca Ltd | Pyridazino quinoline compounds |
| GB9507318D0 (en) * | 1995-04-07 | 1995-05-31 | Zeneca Ltd | Alpha substituted pyridazino quinoline compounds |
| AU2420201A (en) * | 1999-12-23 | 2001-07-09 | Astrazeneca Ab | Compounds and methods for the treatment of pain |
| US6787547B2 (en) | 1999-12-23 | 2004-09-07 | Astrazeneca Ab | Compound and method for the treatment of pain |
| US20030181449A1 (en) * | 1999-12-23 | 2003-09-25 | Urbanek Rebecca Ann | Methods and compositions for the treatment of pain |
| US20030176435A1 (en) * | 2002-12-17 | 2003-09-18 | Brown Dean Gordon | Compounds and methods for the treatment of pain |
| EP1244663B1 (fr) * | 1999-12-23 | 2004-08-25 | AstraZeneca AB | Composes et procedes pour le traitement de la douleur |
| JP2003518500A (ja) * | 1999-12-23 | 2003-06-10 | アストラゼネカ・アクチエボラーグ | 痛みの処置のための方法および組成物 |
| IL150202A0 (en) * | 1999-12-23 | 2002-12-01 | Astrazeneca Ab | Method and composition for the treatment of pain |
| US6730675B2 (en) | 1999-12-23 | 2004-05-04 | Astrazeneca Ab | Compounds and methods for the treatment of pain |
| DE60019807T2 (de) * | 1999-12-23 | 2006-01-19 | Astrazeneca Ab | Pyridazino-quinolin derivat und verfahren zur behandlung von schmerz |
| EP1577311A1 (fr) * | 1999-12-23 | 2005-09-21 | AstraZeneca AB | Sels de composé pyridazino quinoline et utilisation dans le traitement de la douleur |
| US6943165B2 (en) * | 1999-12-23 | 2005-09-13 | Astrazeneca Ab | Compound and method for the treatment of pain |
| WO2001047925A1 (fr) * | 1999-12-23 | 2001-07-05 | Astrazeneca Ab | Composes et methodes de traitement de la douleur |
| US6403818B1 (en) | 2000-02-28 | 2002-06-11 | Eisai Co., Ltd. | Process for producing α-hydroxy-carbonyl compound |
| WO2002026738A1 (fr) * | 2000-09-29 | 2002-04-04 | Astrazeneca Ab | 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES ET LEUR UTILISATION POUR TRAITER LA DOULEUR |
| WO2002026739A1 (fr) * | 2000-09-29 | 2002-04-04 | Astrazeneca Ab | 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones et leur utilisation pour le traitement de la douleur |
| US6946463B2 (en) | 2000-09-29 | 2005-09-20 | Astrazeneca Ab | 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| JP2004509964A (ja) * | 2000-09-29 | 2004-04-02 | アストラゼネカ・アクチエボラーグ | ７−クロロ−４−ヒドロキシ−２−（２−ピリジルエチル）−１，２，５，１０−テトラヒドロピリダジノ［４，５−ｂ］キノリン−１，１０−ジオン及び疼痛治療のためのその使用 |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| RS95003A (en) * | 2001-05-31 | 2007-02-05 | Sanofi-Aventis, | Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| AU2003301513A1 (en) | 2003-08-04 | 2005-02-15 | Valery Khazhmuratovich Zhilov | Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| ME02970B (fr) | 2004-06-24 | 2018-07-20 | Vertex Pharma | Modulateurs de transporteurs de cassette de liaison a l ́ATP |
| US20090105272A1 (en) * | 2005-12-24 | 2009-04-23 | Grootenhuis Peter D J | Prodrugs of modulators of ABC transporters |
| LT1993360T (lt) | 2005-12-28 | 2017-06-12 | Vertex Pharmaceuticals Incorporated | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma |
| EP2821400B1 (fr) | 2009-03-20 | 2017-09-27 | Vertex Pharmaceuticals Incorporated | Procédé pour faire des modulateurs de régulateur de conductance transmembranaire de la fibrose kystique |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| WO2013130669A1 (fr) | 2012-02-27 | 2013-09-06 | Vertex Pharmaceuticals Incorporated | Composition pharmaceutique et son administration |
| AU2015330923B2 (en) | 2014-10-07 | 2020-03-12 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9109972D0 (en) * | 1991-05-09 | 1991-07-03 | Ici Plc | Therapeutic compounds |
| GB9208511D0 (en) * | 1991-05-09 | 1992-06-03 | Ici Plc | Compounds |
| GB9420590D0 (en) * | 1993-10-22 | 1994-11-30 | Zeneca Ltd | Pyridazino quinoline compounds |
| GB9422894D0 (en) * | 1994-11-12 | 1995-01-04 | Zeneca Ltd | Pyridazino quinoline compounds |
| GB9507318D0 (en) * | 1995-04-07 | 1995-05-31 | Zeneca Ltd | Alpha substituted pyridazino quinoline compounds |
-
1994
- 1994-10-12 GB GB9420590A patent/GB9420590D0/en active Pending
- 1994-10-12 IL IL11126694A patent/IL111266A/xx not_active IP Right Cessation
- 1994-10-20 DK DK00101917T patent/DK1004582T3/da active
- 1994-10-20 CA CA002171332A patent/CA2171332A1/fr not_active Abandoned
- 1994-10-20 SK SK504-96A patent/SK282491B6/sk not_active IP Right Cessation
- 1994-10-20 UA UA96041567A patent/UA60291C2/uk unknown
- 1994-10-20 EP EP00101917A patent/EP1004582B1/fr not_active Expired - Lifetime
- 1994-10-20 MY MYPI94002796A patent/MY124316A/en unknown
- 1994-10-20 DE DE69434380T patent/DE69434380T2/de not_active Expired - Fee Related
- 1994-10-20 MY MYPI98002508A patent/MY132875A/en unknown
- 1994-10-20 NZ NZ275472A patent/NZ275472A/en not_active IP Right Cessation
- 1994-10-20 AU AU79440/94A patent/AU688393B2/en not_active Ceased
- 1994-10-20 WO PCT/GB1994/002295 patent/WO1995011244A1/fr active IP Right Grant
- 1994-10-20 AT AT94930275T patent/ATE198072T1/de not_active IP Right Cessation
- 1994-10-20 SI SI9430314T patent/SI0724583T1/xx unknown
- 1994-10-20 SG SG1996007261A patent/SG59971A1/en unknown
- 1994-10-20 EP EP94930275A patent/EP0724583B1/fr not_active Expired - Lifetime
- 1994-10-20 CZ CZ19961138A patent/CZ292311B6/cs not_active IP Right Cessation
- 1994-10-20 AT AT00101917T patent/ATE295846T1/de not_active IP Right Cessation
- 1994-10-20 PT PT94930275T patent/PT724583E/pt unknown
- 1994-10-20 PT PT00101917T patent/PT1004582E/pt unknown
- 1994-10-20 JP JP51152195A patent/JP3583132B2/ja not_active Expired - Fee Related
- 1994-10-20 SG SG9900943A patent/SG92630A1/en unknown
- 1994-10-20 PL PL94314041A patent/PL180679B1/pl not_active IP Right Cessation
- 1994-10-20 HU HU9600889A patent/HUT74161A/hu unknown
- 1994-10-20 DE DE69426422T patent/DE69426422T2/de not_active Expired - Fee Related
- 1994-10-20 US US08/637,641 patent/US5744471A/en not_active Expired - Fee Related
- 1994-10-20 CN CN94194578A patent/CN1053189C/zh not_active Expired - Fee Related
- 1994-10-20 KR KR1019960702011A patent/KR100261209B1/ko not_active IP Right Cessation
- 1994-10-20 ES ES94930275T patent/ES2154686T3/es not_active Expired - Lifetime
- 1994-10-20 DK DK94930275T patent/DK0724583T3/da active
- 1994-10-20 RU RU96109470/04A patent/RU2168511C2/ru not_active IP Right Cessation
- 1994-10-20 ES ES00101917T patent/ES2241513T3/es not_active Expired - Lifetime
- 1994-10-20 SI SI9430476T patent/SI1004582T1/xx unknown
- 1994-10-20 NZ NZ329303A patent/NZ329303A/xx not_active IP Right Cessation
- 1994-11-18 TW TW083110721A patent/TW406082B/zh not_active IP Right Cessation
-
1996
- 1996-04-18 FI FI961696A patent/FI113865B/fi active
- 1996-04-19 NO NO961584A patent/NO306995B1/no not_active IP Right Cessation
-
1997
- 1997-03-03 FI FI970907A patent/FI114916B/fi active IP Right Grant
-
1998
- 1998-03-19 US US09/044,109 patent/US6232313B1/en not_active Expired - Fee Related
- 1998-05-27 AU AU68999/98A patent/AU721139B2/en not_active Ceased
- 1998-12-24 HK HK98115415A patent/HK1013997A1/xx not_active IP Right Cessation
-
1999
- 1999-12-06 US US09/455,096 patent/US6103721A/en not_active Expired - Fee Related
-
2000
- 2000-12-14 GR GR20000402690T patent/GR3035080T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9420590D0 (en) | Pyridazino quinoline compounds | |
| DE69428476T2 (de) | Heterocyclische Verbindungen als Bradykinin Antagonisten | |
| EA199900927A1 (ru) | Трициклические соединения | |
| ES8600288A1 (es) | Un procedimiento para la preparacion de derivados de quinolina. | |
| DE69217312D1 (de) | Tricyclische Heterocyclen als PGE2-Antagonisten | |
| SE9904177D0 (sv) | Novel compounds | |
| DE69207182D1 (en) | Antitumor anthracenderivate | |
| DE69316392D1 (de) | Azanoradamantane | |
| ES2063177T3 (es) | Antagonistas de calcio. | |
| FR2342063A2 (fr) | Nouveaux acetamidoximes, leur procede de preparation et leur application en therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20091020 |